2[2]Engstron G,Lind P,Heelblad B,et al.Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men[J].Circulation,2002,105 (22),3632.
3[3]Heeschen C,Hamm CW,Bruemmer J,et al.Predictive value of C-reactive protein and troponin T in patients with unstahle angina:A comparative analysis[J].JACC,2000,35(6):1535.
3Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Evaluation Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol (Adults Treatment Panel Ⅲ )[J]. JAMA,2001, 285:2486-2497.
4The Long-Term Intervention with Pravastatin in Ischemic Disense (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad rang of initial cholesterol level[J]. N Engl J Med, 1998, 339:1349-1357.
5Mueck AO, Seeger H. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules [J].Eacp Clin Endocrinol Diabetes, 2001,I09:181-183.
6Musisal J, Undas A, Gajewski P, et al. anti-inflammatory effects of Simvastatin in subjects with hypercholesterolemia[J]. Int J Cardiol, 2001, 7:247-1253.
7Wong B, Lumma WC, Smith AM, et al. Statins suppress TGP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranyl-geranglation [J].J Leukoc Biol, 2001.69,959- 962.
8Capurse A. Le Promesse delle statine. [The promise of statins] [J].Ital Heart J,2001, 2:224 -229.
9Chirkov YY, Holmes AS, Willoughby SR, et al. Stable angina and acute coronary syndromes are associate with nitric oxide resistance in platelets [J]. J Am Coll Cardiol, 2001, 37:1851-1857.
10Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor Ⅴ and ⅩⅢ and by enhanceing factor V a inactivation [J]. Circulation,2001,103 : 2248- 2253.
